Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis

Lupus

Volumn 9, Issue 7, 2000, Pages 504-510

  Nossent, H ^a   Berden, J ^b   Swaak, T ^c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Zuiderziekenhuis   (Netherlands)

Author keywords

Immune deposits; Immunofluorescence; Lupus nephritis; Renal survival

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; DNA ANTIBODY; FIBRIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL;

ADOLESCENT; ADULT; COMPLEMENT C1Q; COMPLEMENT C3; FEMALE; FIBRIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033817799     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120330000900705     Document Type: Article

References (33)

1. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies
2. Antibodies to DNA
3. Lupus nephritis
4. Renal transplantation for systemic lupus erythematosis: Excellent long-term results with both living and cadaveric donors
5. Lupus nephritis patients on maintenance dialysis in Hong Kong
6. Dialysis and transplantation in patients with renal failure due to systemic lupus erythematosus. The Australian and New Zealand experience
7. Systemic lupus erythematosus after renal transplantation: Patient and graft survival and disease activity. The Dutch Working Party on Systemic Lupus Erythematosus
8. Prognostic factors in lupus nephritis. Contribution of renal histologic data
9. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy
10. Morphological parameters in lupus nephritis: Their relevance for classification and relationship with clinical and histological findings and outcome
11. Comparison of immunofluorescent findings in kidney after snap-freezing and formalin fixation
12. The 1982 revised criteria for the classification of systemic lupus erythematosus
13. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients
14. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis
15. A reevaluation of routine electron microscopy in the examination of native renal biopsies
16. Current role of renal biopsy in patients with SLE
17. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients
18. The pathogenesis and prognosis of lupus nephritis: Information from repeat renal biopsy
19. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data
20. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group
21. Nucleosomes and the pathogenesis of lupus nephritis
22. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis
23. Relation between serological data at the time of biopsy and renal histology in lupus nephritis
24. Mechanism of progression of renal damage in lupus nephritis: Pathogenesis of renal scarring
25. Prevention of progression of nephropathy
26. IgM anti-dsDNA antibocies in systemic lupus erythematosus: Negative associarion with nephritis
27. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
28. Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: Remodelling of the glomerular lesions by bystander IgM antibodies
29. Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus
30. IgA anti-dsDNA antibodies in systemic lupus erythematosus: Occurrence, incidence and association with clinical and laboratory variables of disease activity
31. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies
32. Pathologic differences between lupus and nonlupus membranous glomerulopathy